Lifeist’s Mikra Increases Active Subscriptions, Plans to Launch CELLF v1.2, Expands Marketing and Product Initiatives, The Canadian Business Journal

TORONTO, September 15, 2022 (GLOBE NEWSWIRE) — Lifeist Wellness Inc. (“Lifeist” or “we”) (TSXV: LFST) (FRANKFURT: M5B) (OTCMKTS: NXTTF)Mikra Cellular Sciences Inc. (“Mikra”), a U.S. biosciences subsidiary, today announced its active announced a 173% increase in monthly subscribers. Q3 2022 compared to CELLF Q2 2022^TMs, the first product to fight brain fog and unlock healthy aging at the cellular level. This level of compounded growth highlights his Mikra ambition to carve out a significant segment in the emerging cellular health category.

Lifeist CEO Meni Morim said: “This business is generating a positive ROI on marketing spend, lowering customer acquisition costs, and offering favorable product margins. It’s about scaling better and providing a stable growth base of continued earnings to invest in future growth initiatives.”

Morim continues: We are investing in product innovation, investing additional marketing dollars and expanding manufacturing capacity. Mikra is increasingly well positioned as Lifeist’s value creation engine. ”

selfie v1.2

Launching in Q4 2022, CELLF v1.2 is the latest innovation in CELLF, Mikra’s flagship line of the latest multivitamins for cellular health. CELLF v1.2 advances Mikra’s three main goals.

1. Expand your distro. There is considerable inbound demand for CELLF from small, medium and large chain wholesalers. This latest version of his CELLF follows “in stock” best practices to reduce package size while also reducing shipping and logistic costs such as storage. These improvements are expected to facilitate future distribution expansion of his CELLF in online marketplaces and physical stores.
2. Improve customer lifetime value. Taste improvements, package formulations and environmental considerations have all been addressed in CELLF v1.2. In this latest version, CELLF’s sachet system is fully recyclable and utilizes ‘easy to dispense’ technology for the consumer to easily consume his CELLF with one hand. Without affecting the delivery mechanism or adding sugar, the Mikra team dramatically improved the taste of his CELLF, one of the key factors in customer churn.
3. Improve profitability and growth. Margins and distribution are a key focus for Mikra, and CELLF v1.2 is expected to deliver product gross margins of over 65%, primarily due to increased order volumes and formulation and supply chain efficiencies. This incremental improvement of his CELLF will open up more delivery opportunities within Q4 2022.

Expansion of marketing activities

As Mikra’s brand footprint grows, so does engagement across all social channels and numerous earned media opportunities. Olympic champion Cullen Jones has extended his partnership with Mikra by launching an in-depth partnership with his Gear Patrol, a men’s daily magazine covering everything from gear, travel, adventure, design, food and culture. deepened. Scheduled to launch in Q4 2022, the partnership will focus on how CELLF impacted Jones’ performance and life.

Restricted Stock Unit Awards (“RSUs”) and Option Awards

Lifeist’s board of directors (the “Board”) has granted a total of 2,084,210 RSUs in favor of two non-employee directors after yesterday’s market close, in favor of former non-employee directors who resigned in July 2022. Granted 468,421 RSUs and retained 2,552,631 shares of common stock. Issued in connection therewith pursuant to the rules of the TSX Venture Exchange and our restricted stock unit plan adopted by our shareholders in his 2020 AGM. Three-quarters of the RSUs granted to the two non-employee directors (total of 1,563,157 RSUs) will vest immediately and the remaining one-quarter of the RSUs granted to such individuals will expire in November 2022 Vests on the 30th. The director’s best soon.

Non-cash compensation (RSUs and deferred stock units (“DSUs”)) constitutes 65% of the baseline compensation paid to our non-employee directors. One non-employee director previously elected to receive non-cash baseline compensation for her fiscal year 2022 in the form of her DSU. To that end, the Company has issued to such Director his 495,000 DSUs in connection with services rendered in the second quarter of 2022 calendar quarter. Pursuant to our Deferred Stock Unit Plan, DSU’s price will be determined based on his June 30, 2022 closing price of our common stock on the TSX Venture Exchange. DSUs vest immediately but may not be exercised until a director resigns from the board, so DSUs align the interests of company directors and shareholders.

In addition, the Board of Directors oversees the TSX Venture Exchange and our stock option plans. Stock options granted have a two-year term, two-thirds of which are granted immediately and one-third are split into two halves of 6 months and 12 months from the date of grant, and expire on September 14, 2024 To do.

About Lifeist Wellness Co., Ltd.

Lifeist is at the forefront of the post-pandemic wellness revolution, leveraging advances in science and technology to build breakthrough companies that transform human wellness. Portfolio business units include: CannMart operates a B2B wholesale distribution business that facilitates the sale of recreational cannabis to Canadian Provincial Government Commissions. CannMart Labs, his BHO extraction facility for producing high-margin Cannabis 2.0 products. Australian Vapes, Australia’s largest online retailer of vaporizers and accessories. and Mikra, a bioscience and consumer wellness company seeking to develop innovative treatments for cellular health.

Information about Lifeist and its businesses can be accessed through the links below.

www.lifeist.com
https://www.roilty.co
www.australianvaporizers.com.au
www.wearemikra.com

contact address

Meni Morim, CEO, Lifeist Wellness Inc.
Matt Chesler, CFA, FNK IR, Investor Relations
Phone: 647-362-0390
Email: [email protected]

Neither the TSX Venture Exchange nor its regulated service providers (as those terms are defined in the TSX Venture Exchange Policy) are responsible for the adequacy or accuracy of this release. .

Forward-Looking Information

This news release contains “forward-looking information” within the meaning of applicable securities laws. All statements contained herein that are not historical in nature contain forward-looking information. Forward-looking information is classified as “likely,” “expect,” “likely,” “should,” “will,” “plan,” “expect,” and “intend.” “will”, “may”, “proposed”, “estimate”, “believe” or any negative form of these terms or other similar words, expressions and grammatical variations thereof, or A statement that a particular event or condition “may occur” or “will occur.”

Forward-looking information contained herein, including statements relating to Mikra’s anticipated development and deployment of CELLF v1.2 and the resulting expected product gross margin growth, includes but is not limited to: Not limited. This includes, but is not limited to, the expectation that CELLF v1.2 and other cell health products we develop will be developed and marketed in a timely manner as expected. Gain or continue to gain market acceptance as the nutraceutical product market expands; that the nutraceutical market develops in line with current expectations; remain a high-percentage market, generate additional revenue for introduced new products and brands, and other considerations as deemed appropriate. Operate according to the situation. Although these assumptions are believed by management to be reasonable based on currently available information, there can be no assurance that such expectations will prove correct. By their nature, forward-looking information is subject to inherent risks and uncertainties, either general or specific, and it is possible that expectations, projections, projections, forecasts or conclusions may not prove to be accurate, or assumptions made. may be incorrect. Its objectives, strategic goals and priorities will not be met. A number of factors, including known and unknown risks, many of which are beyond our control, could cause actual results to differ materially from the forward-looking information contained in this news release. Such factors include the company’s inability to develop CELLF v1.2 or Mikra’s overall business as expected, unforeseen changes to current regulations that adversely affect Mikra’s business, and unforeseen changes that slow Mikra’s ability to sell. Including but not limited to deployment. the risk that demand for CELLF v1.2 or other dietary supplements, dietary supplements in general, and Mikra in particular, will not develop as expected, and the risks associated with our ability to execute our business strategies and the realizable returns therefrom; . Additional risk factors are also described in our current MD&A and Annual Information Forms filed under our SEDAR profile at www.sedar.com. Readers are cautioned not to place undue reliance on forward-looking information. We undertake no obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable law. Any forward-looking statements contained in this news release are expressly qualified by this cautionary statement.

Source: Lifeist Wellness Co., Ltd.

CBJ Newsmaker